Adrian Rawcliffe insider trades: Wave Life Sciences (WVE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adrian reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | WVE | ↓ Sell | 12,700 | $5.29 | $67K | Direct | Aug 13, 2026 (1d) |
| Dec 8, 2025 | WVE | ↓ Sell | 42,000 | $15.00 | $630K | Direct | Dec 10, 2025 (2d) |
| Nov 13, 2025 | WVE | ↓ Sell | 16,115 | $6.79 | $109K | Direct | Nov 14, 2025 (1d) |
| Jan 17, 2025 | ADAP | ↓ Sell | 30,601 | $0.58 | $18K | Direct | Jan 17, 2025 (0d) |
| Jan 15, 2025 | ADAP | ↓ Sell | 59,569 | $0.58 | $35K | Direct | Jan 15, 2025 (0d) |
| Jan 17, 2024 | ADAP | ↓ Sell | 39,384 | $0.70 | $28K | Direct | Jan 17, 2024 (0d) |
| Jan 12, 2024 | ADAP | ↓ Sell | 29,202 | $0.85 | $25K | Direct | Jan 12, 2024 (0d) |
| Sep 1, 2023 | ADAP | ↓ Sell | 2,403 | $0.78 | $2K | Direct | Sep 1, 2023 (0d) |
| Jun 27, 2023 | ADAP | ↓ Sell | 2,333 | $0.92 | $2K | Direct | Jun 27, 2023 (0d) |
| Jan 17, 2023 | ADAP | ↓ Sell | 10,057 | $1.86 | $19K | Direct | Jan 17, 2023 (0d) |
| Jan 12, 2023 | ADAP | ↓ Sell | 31,805 | $1.72 | $55K | Direct | Jan 12, 2023 (0d) |
| Jan 4, 2023 | ADAP | ↓ Sell | 5,073 | $1.69 | $9K | Direct | Jan 4, 2023 (0d) |
| Sep 1, 2022 | ADAP | ↓ Sell | 2,536 | $1.97 | $5K | Direct | Sep 1, 2022 (0d) |
| Jun 27, 2022 | ADAP | ↓ Sell | 2,562 | $1.63 | $4K | Direct | Jun 27, 2022 (0d) |
| Jan 18, 2022 | ADAP | ↓ Sell | 11,096 | $3.19 | $35K | Direct | Jan 18, 2022 (0d) |
| Jan 12, 2022 | ADAP | ↓ Sell | 17,408 | $3.55 | $62K | Direct | Jan 13, 2022 (1d) |
| Jan 4, 2022 | ADAP | ↓ Sell | 5,532 | $4.06 | $22K | Direct | Jan 5, 2022 (1d) |
| Sep 1, 2021 | ADAP] | ↓ Sell | 2,782 | $5.20 | $14K | Direct | Sep 1, 2021 (0d) |
| Jun 28, 2021 | ADAP | ↓ Sell | 2,794 | $4.37 | $12K | Direct | Jun 28, 2021 (0d) |
| Jan 19, 2021 | ADAP | ↓ Sell | 9,879 | $5.67 | $56K | Direct | Jan 19, 2021 (0d) |
| Jan 12, 2021 | ADAP | ↓ Sell | 2,707 | $6.15 | $17K | Direct | Jan 12, 2021 (0d) |
| Jan 4, 2021 | ADAP | ↓ Sell | 4,967 | $5.33 | $26K | Direct | Jan 5, 2021 (1d) |
| Sep 1, 2020 | ADAP | ↓ Sell | 2,776 | $8.51 | $24K | Direct | Sep 2, 2020 (1d) |
| Aug 3, 2020 | ADAP | ↓ Sell | 2,788 | $9.25 | $26K | Direct | Aug 4, 2020 (1d) |
| Jan 14, 2020 | ADAP | ↓ Sell | 3,236 | $5.13 | $17K | Direct | Jan 15, 2020 (1d) |
| Jan 6, 2020 | ADAP | ↓ Sell | 5,900 | $1.20 | $7K | Direct | Jan 7, 2020 (1d) |
| Jan 14, 2019 | ADAP | ↓ Sell | 3,084 | $5.37 | $17K | Direct | Jan 16, 2019 (2d) |
| Mar 20, 2018 | ADAP | ↓ Sell | 600,000 | $1.71 | $1.0M | Direct | Mar 22, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other WVE insiders
Open-market trades in the last 12 months
About Adrian Rawcliffe's insider trades
Adrian Rawcliffe is an insider at Wave Life Sciences (WVE). Since Mar 20, 2018, Adrian has reported no open-market purchases and 28 sales worth $2.4M on SEC Form 4. In the last 12 months: 3 sales ($807K).
Their filings also include grants and awards (23 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WVE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.